Marimed Inc. (OTC:MRMD)
| Market Cap | $19.08M-43.8% |
| Revenue (ttm) | $167.28M+6.3% |
| Net Income | -$15.51M+13.2% |
| EPS | -$0.04+16.5% |
| Shares Out | 406.00M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100,441 |
| Open | $0.05 |
| Previous Close | $0.05 |
| Day's Range | $0.05 - $0.05 |
| 52-Week Range | $0.04 - $0.16 |
| Beta | 1.40 |
| Analysts | Buy |
| Price Target | $2.25(+4687.23%) |
| Earnings Date | Mar 17, 2027 |
About MRMD
MariMed Inc. operates in the cannabis industry, specializing in the cultivation, production, and sale of both medicinal and adult-use cannabis items throughout the United States and internationally. The company's diverse product portfolio includes cannabis flowers and concentrates marketed under the Nature's Heritage brand. It also offers infused goods such as chewable tablets and powdered drink mixes under the Kalm Fusion label, natural fruit chews known as Betty's Eddies, and a line of baked treats like brownies and cookies available through Bubby's Baked. Furthermore, MariMed develops cannabidiol (CBD) products under the Florance brand. Beyond its own offerings, the company licenses its various brands and product formulations to others and leases facilities designed for cannabis operations. MariMed Inc., founded in 2011, is based in Norwood, Massachusetts.
Next catalysts
- Mar 17, 2027Earnings report
$MRMD stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in MRMD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MRMD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MRMD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New MRMD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MRMD from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MRMD
| MSOSAdvisorShares Pure US Cannabis ETF | $333.28K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from MRMD’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 2026 earnings beat with record revenue and positive GF Value upside estimates drive bullish coverage, though limited detail on forward guidance.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| MSOS | AdvisorShares Pure US Cannabis ETF | 0.05% |
Weight is the stock’s share of each fund’s holdings.
